KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $784.0 million.

  • Elevance Health's Net Cash Flow rose 6470.59% to $784.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year decrease of 3413.3%. This contributed to the annual value of $1.2 billion for FY2025, which is 3413.3% down from last year.
  • Elevance Health's Net Cash Flow amounted to $784.0 million in Q4 2025, which was up 6470.59% from $154.0 million recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Net Cash Flow ranged from a high of $3.6 billion in Q1 2021 and a low of -$4.4 billion during Q4 2023
  • For the 5-year period, Elevance Health's Net Cash Flow averaged around $192.6 million, with its median value being $299.0 million (2022).
  • Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 69647.58% in 2021, then soared by 93504.27% in 2022.
  • Elevance Health's Net Cash Flow (Quarter) stood at -$609.0 million in 2021, then plummeted by 144.17% to -$1.5 billion in 2022, then crashed by 195.49% to -$4.4 billion in 2023, then soared by 110.83% to $476.0 million in 2024, then skyrocketed by 64.71% to $784.0 million in 2025.
  • Its last three reported values are $784.0 million in Q4 2025, $154.0 million for Q3 2025, and $1.1 billion during Q2 2025.